FDA Investigator Esther C Broner, PhD
Esther C Broner, PhD has conducted inspections on 7 sites in 2 countries as of 06 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
06 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Israel
FDA Investigators that have inspected at least one site in common with Esther C Broner, PhD:
Adam R Cooke,
Alan L Truong,
Alan P Kurtzberg,
Alifiya H Ghadiali,
Amalia C Himaya,
Amir Alavi,
Andrea Franco,
Andrew J Barrowcliff,
Anita Narula, PhD,
Ashley N Queen, PhD,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Brian S Keefer,
Brien C Fox,
Cara M Minelli,
Carla J Lundi,
Carrie A Hughes,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Chani Broner, PhD,
Charles Yuanchia Kuo, PhD,
Charlotte E Wilkins,
Cheron M Portee,
Christina C Santos,
Christina K Theodorou,
Christina V Santos,
Christopher R Czajka,
Christopher S Keating,
Craig D Zagata,
Cristina Ausin Moreno, PhD,
Cynthia Jim, CSO,
Daniel Lagasse,
Daniel T Lee,
Daniel W Cline,
David G Whitman,
David J Hafner,
Davinna Ligons, PhD,
Diane Cvan Leeuwen,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Eboni S Funderburk,
Edward D Mcdonald,
Edwin Jao,
Emilie E Kahn,
Ephrem Hunde, PhD,
Erika V Butler,
Frances Namuswe, PhD,
Gene D Arcy,
Gerard T Schneider,
Ginger M Sykes,
Grace Deneke,
Grace E Mcnally,
Gregory Price,
Gwyn G Dickinson,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Helen B Ricalde,
Hyung Yul Lee,
Iris C Macinnes,
Isabel Y Espinosa,
Jacob G Lutz,
James A Lane,
James M Mason,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey D Meng,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Jessica S Estriplet,
Joel Welch, PhD,
Joey V Quitania,
John R Myung,
Jon P Antoniou,
Joslyn K Brunelle, PhD,
Junho Pak,
Ka L Wong,
Karen G Hirshfield,
Katherine E Jacobitz,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Kimberley A Hoefen,
Lata C Mathew, PhD,
Latorie S Jones,
Laura Fontan, MS,
Laurimer Kuilan Torres,
LCDR Sean Byrd,
Leonard H Lavi,
Lestine C Webb,
Linda M Cheny,
Linda Thai,
Logan T Williams,
Marcia B Williams,
Marcus F Yambot,
Maria Cruz Fisher,
Mariza M Jafary,
Marlene G Swider,
Maxyne T Lam,
Meisha R Sampson,
Meisha Waters,
Michael A Charles,
Michael A Taylor,
Michael E Maselli,
Michael J Kuchta,
Michael R Goga,
Michael S Araneta,
Michael Shanks, MS,
Michael T Cyrus,
Michele L Forster, PhD,
Michele Perry Williams,
Michelle A Marsh,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Muna Algharibeh,
Nancy G Schmidt,
Nayan J Patel,
Nicholas L Paulin,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Patricia A Brown,
Patricia A Cortez,
Peter S Diak,
Prabhu P Raju,
Prajakta A Varadkar,
Rabia Ballica, PhD,
Rafeeq A Habeeb,
Rebecca K Olin,
Rebecca Rodriguez,
Richmond K Yip,
Robert Barbosa,
Robert D Tollefsen,
Robert Darius,
Robert M Barbosa,
Roger F Zabinski,
Roger L Farmer,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Sandra A Boyd,
Santiago Gallardo Johnson,
Sarah Arden,
Sargum C Sood,
Scott R Nichols, PhD,
Seneca D Toms,
Sidney B Priesmeyer,
Sneha S Patel,
Song Y Lavalais,
Sonia R Peterson,
Sonya M Edmonds,
Stanley Au,
Steve Y Rhieu, PhD,
Steven Fong, MS, PhD,
Susan F Laska, MS,
Taichun Qin, PhD,
Tamika White,
Tara L Breckenridge,
Tara L Greene,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thuy T Nguyen, LCDR,
Timothy J Schmidt,
Uttaniti Limchumroon (Tom),
Vaishali J Patel,
Veronica Fuentes, MS,
Virgilio F Pacio, CSO,
Virginia Carroll, PhD,
Viviana Matta,
Vlada Matusovsky,
Wayne E Seifert,
Wendy G Tan, PhD,
Yanming An, PhD,
Yi Wang, PhD,
Yuan Chia Kuo,
Yumi J Hiramine,
Yvins Dezan,
Yvonne C Wilkes,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm,
Zhong Li, PhD
Esther C Broner, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2022 | FDA 483 | Sharp Packaging Services, LLC - Form 483, 2022-09-21 |
| February, 2023 | FDA 483 | Ajinomoto Althea, Inc. - Form 483, 2023-02-09 |
| August, 2022 | FDA 483 | Biogen U.S. Corporation - Form 483, 2022-08-26 |
| May, 2023 | FDA 483 | Catalent Indiana, LLC - Form 483, 2023-05-12 |
| November, 2022 | FDA 483 | MediWound Ltd - Form 483, 2022-11-15 |
| April, 2022 | FDA 483 | Curia New Mexico, LLC - Form 483, 2022-04-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more